INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $42,597,932 | +21.5% | 1,044,579 | +11.1% | 0.05% | +15.9% |
| Q1 2023 | $35,052,286 | +128376.7% | 940,496 | +20.3% | 0.04% | +12.8% |
| Q4 2022 | $27,283 | -99.9% | 781,978 | +2.1% | 0.04% | -39.1% |
| Q3 2022 | $42,874,000 | +30.3% | 766,162 | +20.5% | 0.06% | +39.1% |
| Q2 2022 | $32,912,000 | +23.6% | 635,850 | +73.5% | 0.05% | +53.3% |
| Q1 2022 | $26,636,000 | -46.6% | 366,533 | -13.1% | 0.03% | -40.0% |
| Q4 2021 | $49,893,000 | +45.7% | 421,964 | +65.3% | 0.05% | +31.6% |
| Q3 2021 | $34,238,000 | – | 255,224 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |